“Irisin levels in type 2 diabetes mellitus with and without non-alcoholic fatty liver disease: a case-control study”, Prospect. Pharm. Sci., vol. 22, no. 3, pp. 210–218, Sept. 2024, doi: 10.56782/pps.254.